Literature DB >> 12112193

Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.

J Carsten Möller1, Karin Stiasny, Volker Hargutt, Werner Cassel, Heiko Tietze, J Hermann Peter, H-Peter Krüger, Wolfgang H Oertel.   

Abstract

Six patients with Parkinson's disease (PD) reporting unusually fast or sudden onset of sleep under the addition of dopamine agonists to a previous levodopa-containing therapy were examined using a sleep-wake diary, the Epworth sleepiness scale (ESS), polysomnography, multiple sleep latency tests (MSLT), a standardized vigilance test, and driving simulation. In all patients, ESS scores were increased and polysomnography showed disruption of the sleep pattern, a tendency towards poor sleep efficiency, and reduced proportions of slow- wave and rapid eye movement sleep. Pathological results in the MSLT or the vigilance test were obtained in five cases. For evaluation of driving performance, the standard deviation from the mean lane position during driving simulation was calculated. Three of five patients had clearly increased mean SDLP values. With respect to the measurement of daytime sleepiness (ESS, MSLT, vigilance test, and driving simulation), each patient had pathological results in at least two of these examinations. However, only a limited transfer of the routine vigilance assessment to driving performance was possible. In summary, this pilot study indicates that unusually fast or sudden onset of sleep in PD patients is a phenomenon of daytime sleepiness. Copyright 2002 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112193     DOI: 10.1002/mds.10020

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Impaired Curve Negotiation in Drivers with Parkinson's Disease.

Authors:  Ergun Y Uc; Matthew Rizzo; Elizabeth Dastrup; Jondavid Sparks; Steven W Anderson; Robert L Rodnitzky; Jeffrey D Dawson
Journal:  Turk Noroloji Dergisi       Date:  2009-01-19

2.  Daytime REM sleep in Parkinson's disease.

Authors:  Donald L Bliwise; Lynn Marie Trotti; Jorge J Juncos; Stewart A Factor; Alan Freeman; David B Rye
Journal:  Parkinsonism Relat Disord       Date:  2012-08-29       Impact factor: 4.891

Review 3.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

4.  Sleepiness and Unintended Sleep in Parkinson's Disease.

Authors:  David B. Rye
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

5.  Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.

Authors:  Donald L Bliwise; Lynn Marie Trotti; Anthony G Wilson; Sophia A Greer; Cathy Wood-Siverio; Jorge J Juncos; Stewart A Factor; Alan Freeman; David B Rye
Journal:  Mov Disord       Date:  2012-07-02       Impact factor: 10.338

Review 6.  Driving and neurodegenerative diseases.

Authors:  Ergun Y Uc; Matthew Rizzo
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

Review 7.  Excessive daytime sleepiness and unintended sleep in Parkinson's disease.

Authors:  David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

8.  COLLISION AVOIDANCE TRAINING USING A DRIVING SIMULATOR IN DRIVERS WITH PARKINSON'S DISEASE: A PILOT STUDY.

Authors:  Jeffrey D Dawson; Matthew Rizzo; Steven W Anderson; Elizabeth Dastrup; Ergun Y Uc
Journal:  Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des       Date:  2009-12-01

9.  Sleep disorders in Parkinson's disease.

Authors:  Israt Jahan; Robert A Hauser; Kelly L Sullivan; Amber Miller; Theresa A Zesiewicz
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

10.  Driving under low-contrast visibility conditions in Parkinson disease.

Authors:  E Y Uc; M Rizzo; S W Anderson; E Dastrup; J D Sparks; J D Dawson
Journal:  Neurology       Date:  2009-10-06       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.